Back to Search
DENNIS RIFF, M.D.
M.D.
Specialist
NPI: 1922004662IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
G22807(CA)
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1971
Research & Publications (16)
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.
PMID 19637334·Inflamm Bowel Dis·2010
2-rct
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects.
PMID 19523177·Aliment Pharmacol Ther·2009
4-observational
Comparison of the audiologic results obtained with the bone-anchored hearing aid attached to the headband, the testband, and to the "snap" abutment.
PMID 18957902·Otol Neurotol·2009
8-other
Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitis.
PMID 17593070·Aliment Pharmacol Ther·2007
4-observational
A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
PMID 17216336·Dig Dis Sci·2007
4-observational
A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
PMID 16804392·Inflamm Bowel Dis·2006
3-trial
A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury.
PMID 15067622·Clin Gastroenterol Hepatol·2004
3-trial
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
PMID 12492193·Am J Gastroenterol·2002
3-trial
A study to determine the nitroglycerin ointment dose and dosing interval that best promote the healing of chronic anal fissures.
PMID 12352236·Dis Colon Rectum·2002
3-trial
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
PMID 12094857·Am J Gastroenterol·2002
3-trial
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
PMID 11929393·Aliment Pharmacol Ther·2002
3-trial
Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multicenter phase III trials.
PMID 11726845·Gastrointest Endosc·2001
3-trial
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
PMID 11564000·Aliment Pharmacol Ther·2001
3-trial
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
PMID 11511562·Gut·2001
3-trial
Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
PMID 10763941·Am J Gastroenterol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1211 W LA PALMA AVE, STE 306
ANAHEIM, CA 92801 - Phone
- (714) 778-1300
Quick Facts
- NPI
- 1922004662
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 55
- Publications
- 16
Are you this provider?
Claim Your Profile